Accordingly, copper chelators were used in the treatment of transgenic mice expressing mutated SOD1 associated with familial ALS, leading to an increase in animal viability and an improvement in general condition [47,48,49]. Here, SOD1 is linked to amyotrophic lateral sclerosis.